Jennifer Reavis, MD
Otolaryngology · Colorado Springs, CONPI 1013101146
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,737 of the $2,742 with a category attached, or 63.4%. 11 manufacturers reported payments, led by Medtronic at 42.4% of the total. Reporting peaked in 2020 at $1,163 and has fallen 85.4% since, to $170 in 2024.
Across 30 payments — averaging $91.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Medical Device Business Services, Inc.$790
- Inspire Medical Systems, Inc.$183
- Sanofi$129
- Regeneron Healthcare Solutions, Inc.$123
- Acclarent, Inc$104
- plus $249 from 5 others
What the payments were for
- Travel & lodging$1,73763%
- Food & beverage$1,00537%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 10 | $1,163 |
| Medical Device Business Services, Inc. | 4 | $790 |
| Inspire Medical Systems, Inc. | 2 | $183 |
| Sanofi | 2 | $129 |
| Regeneron Healthcare Solutions, Inc. | 3 | $123 |
| Acclarent, Inc | 1 | $104 |
| Stryker | 3 | $83 |
| Intersect ENT, Inc. | 1 | $61 |
| GSK | 2 | $52 |
| AstraZeneca | 1 | $34 |
| Galderma Laboratories, L.p. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,742 in reported general payments places this provider in the 75th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 45 | $1,652 |
| Mupirocin | 100 | $1,128 |
| Fluticasone Propionate | 36 | $497 |
| Doxycycline Hyclate | 16 | $301 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $88 |
| Prednisone | 28 | $66 |
| Cephalexin | 16 | $63 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $59 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Colorado Springs
- Barton KnoxColorado Springs$164K
- Nicholas BeckmannColorado Springs$151K
- Michael WilhelmColorado Springs$76K
- Robert KellerColorado Springs$45K
- David BookColorado Springs$5K
- Edgar GallowayColorado Springs$5K
- Cameron ToddColorado Springs$4K
- Jonathan ArnholtColorado Springs$4K
- Elycia Kazemian-MarviColorado Springs$4K
- Matthew WhineryColorado Springs$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.